Startup India Government of India
Orosys Pharma Private Limited - pharma in Misrod, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.14 Lakh
▼ 98% YoY
Net loss · FY 2025
₹9.92 Lakh
Latest filing
EBITDA · FY 2025
-₹8.24 Lakh
Latest filing
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered
About Orosys Pharma Private Limited
Data last updated:
Orosys Pharma Private Limited is a private limited company based in Misrod, Madhya Pradesh, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U51909MP2019PTC049352. Its GSTIN is 19AADCO0004A1ZA (West Bengal). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jivnath Jha and Navneet Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P. No. 21B F No. – 4A Maruti Enclave Natraj Colony, Misrod, Madhya Pradesh, India – 462026.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.14 Lakh, a decline of 98% compared to the previous year. For the same year it recorded a net loss of ₹9.92 Lakh and EBITDA of -₹8.24 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 78% over three years.
Orosys Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-06-0012497). For more details, the company can be reached via its website orosyspharma.com.
Company details
CIN U51909MP2019PTC049352
Registration Number 049352
Incorporation Date 19 August 2019
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-WB-06-0012497
Key People
Jivnath Jha Director Navneet Kumar Singh Director Recognitions & Rankings of Orosys Pharma
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-WB-06-0012497
Contact details
Orosys Pharma Private Limited's registered office is in Misrod, Madhya Pradesh. Its website is orosyspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressP. No. 21B F No. – 4A Maruti Enclave Natraj Colony, Misrod, Madhya Pradesh, India – 462026
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Orosys Pharma Private Limited, buy the company report.
Comprehensive company report
Orosys Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Orosys Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Orosys Pharma Private Limited, buy the company report.
Financials of Orosys Pharma Private Limited
FY 2025 filings availableOrosys Pharma Private Limited reported revenue of ₹1.14 Lakh (down 98% YoY) for FY 2025.
Revenue · FY 2025
₹1.14 Lakh ▼ 98%
Net loss · FY 2025
₹9.92 Lakh
EBITDA · FY 2025
-₹8.24 Lakh
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 98%
3 years · compounded
▼ 78%
EBITDA CAGR growth
1 year
▼ 369%
3 years · compounded
▼ 45%
5 years · compounded
▲ 14%
Revenue has declined at a compounded annual rate (CAGR) of 78% over three years, including a 98% fall in the latest year. EBITDA fell 369% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹8.24 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹9.92 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Orosys Pharma Private Limited, buy the company report.
Board of directors of Orosys Pharma Private Limited
Orosys Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jivnath Jha | Director | 16 Jan 2024 | 2 Years 9 Months | Current |
| Navneet Kumar Singh | Director | 19 Aug 2019 | 7 Years 2 Months | Current |
Peer comparison
Orosys Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| KNKN Engineering Works Private Limited | ₹1.14 Lakh (FY 2025) | -81.0% | Jaunpur, Uttar Pradesh, India | |||
| Sunchasers Exports Private Limited | ₹1.14 Lakh (FY 2021) | 61.0% | Pune, Maharashtra, India | |||
| Yadson Tradecom Private Limited | ₹1.14 Lakh (FY 2022) | 295.0% | Kolkata, West Bengal, India | |||
| Unc Sports Private Limited | ₹1.14 Lakh (FY 2021) | Jalandhar, Punjab, India | ||||
| Jiveda Laboratories Private Limited | ₹1.14 Lakh (FY 2025) | New Delhi, Delhi, India | ||||
| Orosys Pharma Private Limitedthis company | ₹1.14 Lakh (FY 2025) | -₹9.92 Lakh | -98.0% | Misrod, Madhya Pradesh, India | ||
| Progenex Solutions Private Limited | ₹1.14 Lakh (FY 2016) | Pune, Maharashtra, India | ||||
| Zivot Medicament Private Limited | ₹1.14 Lakh (FY 2024) | 162.0% | Kanpur, Uttar Pradesh, India | |||
| Ronsher Pharmaceutical Private Limited | ₹1.14 Lakh (FY 2024) | Khargone, Madhya Pradesh, India | ||||
| Biogreat Pharma Private Limited | ₹1.14 Lakh (FY 2021) | Agra, Uttar Pradesh, India | ||||
| Nivit Techworld India Private Limited | ₹1.14 Lakh (FY 2025) | -8.0% | New Delhi, Delhi, India |
To see the full peer comparison of Orosys Pharma Private Limited, buy the company report.
Shareholding
The shareholding of Orosys Pharma Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Orosys Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Orosys Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Orosys Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Orosys Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AADCO0004A1ZA | West Bengal | Active | 06 Apr 2021 |
To see the full GST registrations and return filing status of Orosys Pharma Private Limited, buy the company report.
Recent activity
Orosys Pharma Private Limited has 5 board changes on record since 2019: 2 appointments and 3 cessations. The latest: Neeraj Kumar Singh ceased to be Director on 17 Jan 2024.
AGM
Orosys Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Orosys Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Ceased
Neeraj Kumar Singh ceased to be Director.
Appointed
Jivnath Jha was appointed as Director.
Ceased
Abhishek Ghosh ceased to be Director.
Ceased
Anshu Kumar Singh ceased to be Director.
Appointed
Navneet Kumar Singh was appointed as Director.
Incorporation
19 Aug 2019
Orosys Pharma Private Limited was registered on 19 Aug 2019 with Roc Gwalior & aged 7 years 2 months as per MCA records.
Frequently asked questions
Orosys Pharma is an active private limited company based in Misrod, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 August 2019 (7+ years old) and is registered under CIN U51909MP2019PTC049352.
Orosys Pharma has 2 current directors:
- Jivnath Jha - Director
- Navneet Kumar Singh - Director
The latest financial statements of Orosys Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Orosys Pharma is 19AADCO0004A1ZA, registered in West Bengal. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Orosys Pharma is U51909MP2019PTC049352. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Orosys Pharma was incorporated on 19 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Orosys Pharma by revenue are KNKN Engineering Works Private Limited, Sunchasers Exports Private Limited, Yadson Tradecom Private Limited, Unc Sports Private Limited, Jiveda Laboratories Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Neeraj Kumar Singh ceased to be Director on 17 Jan 2024. Jivnath Jha was appointed as Director on 16 Jan 2024. Abhishek Ghosh ceased to be Director on 10 Feb 2023. Orosys Pharma has 5 board changes on record in total.
Yes, Orosys Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Orosys Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-06-0012497).
Orosys Pharma can be reached through the website orosyspharma.com. Its registered office is in Misrod, Madhya Pradesh, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages